Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -79.66%5.92M | 67.08%26.45M | 74.89%32.03M | 142.00%97.97M | 253.15%34.69M | 121.90%29.13M | 2,256.68%15.83M | 0.27%18.32M | -61.55%40.48M | -21.73%9.82M |
| Net income from continuing operations | -97.51%1.87M | 791.16%3.52M | -124.34%-1.11M | 407.86%82.22M | 998.12%8.12M | 1,015.62%75.1M | 98.13%-509K | -105.14%-493K | -123.23%-26.71M | -107.36%-904K |
| Operating gains losses | -79.21%21K | 110.56%15K | 188.89%56K | -232.84%-271K | -161.85%-167K | 365.79%101K | -407.14%-142K | ---63K | 139.01%204K | -11.48%270K |
| Depreciation and amortization | -23.09%10.1M | 41.49%13.66M | 35.38%13.85M | 56.15%40.74M | 50.99%7.71M | 112.20%13.14M | 219.87%9.66M | -13.08%10.23M | -44.00%26.09M | -82.21%5.11M |
| Remuneration paid in stock | 212.92%1.48M | 13.19%1M | 270.44%3.47M | 57.65%3.19M | 138.83%898K | 49.84%472K | -22.87%887K | 406.49%937K | -9.96%2.03M | -31.51%376K |
| Other non cashItems | 106.09%3.97M | 32.48%7.59M | -13.82%6.29M | -252.39%-46.16M | -5.11%6.08M | -899.98%-65.25M | -25.29%5.73M | -9.53%7.29M | 223.69%30.29M | 525.30%6.41M |
| Change In working capital | -306.71%-11.52M | 214.29%660K | 2,205.84%9.48M | 112.63%18.25M | 941.55%12.05M | -16.86%5.57M | -98.57%210K | 103.62%411K | 125.61%8.58M | 94.85%-1.43M |
| -Change in receivables | -387.83%-6.74M | -51.28%819K | 723.26%8.5M | 26.73%17.67M | 4,080.44%12.62M | -3.98%2.34M | -90.21%1.68M | 119.30%1.03M | 128.55%13.95M | 87.88%-317K |
| -Change in payables and accrued expense | -235.22%-4.88M | 48.76%-290K | 136.53%746K | 107.37%393K | 16.37%-608K | 18.02%3.61M | 28.54%-566K | 70.29%-2.04M | -134.13%-5.33M | 97.14%-727K |
| -Change in other current assets | 125.20%95K | 108.14%79K | -84.31%223K | 1,200.00%55K | 94.88%-19K | -131.21%-377K | 43.44%-970K | 62.77%1.42M | -101.60%-5K | -188.76%-371K |
| -Change in other working capital | 0.00%1K | -20.00%52K | --12K | 604.00%126K | 452.94%60K | --1K | 1,028.57%65K | ---- | 95.82%-25K | 88.36%-17K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -79.66%5.92M | 67.08%26.45M | 74.89%32.03M | 142.00%97.97M | 253.15%34.69M | 121.90%29.13M | 2,256.68%15.83M | 0.27%18.32M | -61.55%40.48M | -21.73%9.82M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 84.58%-1.17M | 56.54%1.5M | 807.88%5.75M | 81.80%-4.05M | 289.66%3.36M | -155.63%-7.55M | 115.86%955K | 92.96%-812K | 81.99%-22.28M | 83.82%-1.77M |
| Net PPE purchase and sale | 78.03%-1.75M | 152.19%809K | 347.17%5.11M | 68.69%-8.77M | 209.30%2.81M | -103.48%-7.96M | 80.78%-1.55M | 84.62%-2.07M | -8.35%-28M | 79.90%-2.57M |
| Net intangibles purchas and sale | ---34K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -2,050.00%-43K | ---- |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 99.14%-951K | ---- |
| Interest received (cash flow from investment activities) | 53.48%617K | -72.61%686K | -49.56%634K | -29.82%4.71M | -69.45%548K | -57.91%402K | 22.67%2.51M | -34.63%1.26M | 78.04%6.71M | -2.92%1.79M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 84.58%-1.17M | 56.54%1.5M | 807.88%5.75M | 81.80%-4.05M | 289.66%3.36M | -155.63%-7.55M | 115.86%955K | 92.96%-812K | 81.99%-22.28M | 83.82%-1.77M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -26.45%-17.16M | 19.04%-40.16M | -100.02%-35.24M | -70.51%-89.1M | -138,400.00%-8.31M | 65.32%-13.57M | -99,292.00%-49.6M | -33.82%-17.62M | -10.06%-52.26M | 84.62%-6K |
| Net issuance payments of debt | -265,950.00%-10.64M | 26.91%-34.37M | -78,638.24%-26.77M | -142.89%-49.24M | -36,300.00%-2.18M | 99.98%-4K | -94,144.00%-47.02M | 72.13%-34K | 26.39%-20.27M | 84.62%-6K |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | 54.11%-5.99M | -101.83%-5.2M | 60.58%-6.93M | -23.04%-39.35M | ---6.13M | 31.02%-13.06M | ---2.57M | -34.81%-17.59M | 22.34%-31.98M | --0 |
| Net other financing activities | -3.95%-526K | ---590K | ---1.54M | ---506K | --0 | ---506K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -26.45%-17.16M | 19.04%-40.16M | -100.02%-35.24M | -70.51%-89.1M | -138,400.00%-8.31M | 65.32%-13.57M | -99,292.00%-49.6M | -33.82%-17.62M | -10.06%-52.26M | 84.62%-6K |
| Net cash flow | ||||||||||
| Beginning cash position | 73.40%67.15M | 10.86%79.33M | 7.08%76.8M | -32.16%71.72M | -26.48%46.78M | -58.16%38.73M | -27.93%71.56M | -32.16%71.72M | -38.41%105.73M | -38.93%63.62M |
| Current changes in cash | -255.03%-12.4M | 62.78%-12.21M | 2,267.52%2.54M | 114.14%4.81M | 269.53%29.74M | 127.63%8M | -389.21%-32.81M | 98.18%-117K | 48.32%-34.05M | 412.61%8.05M |
| Effect of exchange rate changes | -163.46%-33K | 273.68%33K | 84.00%-8K | 533.33%266K | 466.00%283K | 44.44%52K | 42.42%-19K | -354.55%-50K | 191.30%42K | 433.33%50K |
| End cash Position | 16.96%54.71M | 73.40%67.15M | 10.86%79.33M | 7.08%76.8M | 7.08%76.8M | -26.48%46.78M | -58.16%38.73M | -27.93%71.56M | -32.16%71.72M | -32.16%71.72M |
| Free cash from | -80.44%4.14M | 85.21%26.45M | 97.17%32.03M | 616.92%89.2M | 420.07%37.5M | 129.72%21.17M | 262.29%14.28M | 237.47%16.25M | -84.34%12.44M | 3,117.15%7.21M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.